data13F

RNA – Atrium Therapeutics Inc

Held by 1 of 60 tracked investors in their latest 13F filing · 0 counted on Most owned (narrow-view filings excluded)

Investors holding1
Combined shares140,874
Combined reported value$1.2M

RNA chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Paul Tudor Jones narrow view 0.01 Added 8.7%140,874$1.2MQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Added 8.7%140,8740.00
Q2 2026Paul Tudor Jones narrow view Added 81.6%129,5910.00
Q1 2026Paul Tudor Jones narrow view New71,3590.01

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Paul Tudor Jones narrow view Added 8.7%140,8740.00
Q2 2026Paul Tudor Jones narrow view Added 81.6%129,5910.00
Q1 2026Paul Tudor Jones narrow view New71,3590.01

Reduced: reduced or closed

No tracked investor reduced or closed this position in the last 4 quarters.

History

1 peakQ3 2026: 1 tracked investors
Q1 2026: 1 tracked investorsQ2 2026: 1 tracked investorsQ3 2026: 1 tracked investors
20262026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Paul Tudor Jones140.9K129.6K71.4K–––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).